#Israel #Inspira Technologies #Ra'anana #Zriha Medical #Respiratory Support

Inspira Technologies Partners with Zriha Medical for Innovative Production Line

In an exciting development in the field of medical innovation, Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) has announced its collaboration with Zriha Medical Ltd., a leading name in medical device manufacturing. This partnership aims to establish a dedicated production line that focuses on a pivotal component of Inspira’s cutting-edge respiratory support system. This initiative is poised to significantly enhance the company’s production capabilities and improve patient care in critical situations.

The collaborative effort will see the integration of a specialized flow mechanism into Inspira's products, which are designed for the extracorporeal circulation of blood during the oxygenation process. Such advancements are crucial, as they involve the innovative technology behind Inspira's Augmented Respiration Technology (INSPIRA™ ART), which aims to provide patients with acute respiratory failure an alternative to conventional mechanical ventilators.

Zriha Medical’s proven expertise in precision assembly within clean room environments aligns perfectly with Inspira’s vision. The establishment of this production line represents a vital milestone in Inspira’s strategy. By leveraging Zriha’s 50 years of experience in advanced plastic and silicone injection, as well as metal processing technologies, the partnership not only accelerates production capabilities but also enhances the overall quality and reliability of the medical devices.

Inspira Technologies is renowned for revolutionizing the $19 billion mechanical ventilation market. Their INSPIRA ART system, designed to stabilize diminishing oxygen saturation levels, allows patients to remain awake during treatment without reliance on a ventilator. This innovative approach addresses a crucial need, particularly with millions suffering from acute respiratory failure across intensive care units worldwide.

Furthermore, the collaborative efforts of both companies ensure that the devices produced will meet stringent quality standards, as evidenced by Zriha Medical's ISO 13485 certification. This adherence to best practices in manufacturing is expected to yield highly reliable products that can effectively support healthcare providers in managing patient care efficiently.

In previous advancements, the INSPIRA™ ART100 system received FDA 510(k) clearance for usage in Cardiopulmonary Bypass (CBP) procedures, in addition to obtaining the Israeli AMAR certification for Extra-Corporeal Membrane Oxygenation. Such regulatory approvals attest to the technology's effectiveness and safety, further solidifying Inspira’s commitment to enhancing respiratory care.

Looking ahead, the innovations stemming from this collaboration could substantially impact how respiratory support systems are integrated into healthcare practices. With a focus on designing new products, including the INSPIRA™ Cardi-ART portable modular device, VORTX™ Oxygen Delivery System, and the HYLA™ blood sensor, the company is poised to provide groundbreaking advancements in patient monitoring and treatment options.

Inspira Technologies stands at the forefront of redefining life-support technology, and alongside Zriha Medical, they hope to make significant strides in improving patient outcomes through innovative solutions. For more information on their technologies and developments, you can visit Inspira Technologies' website.

As the collaboration moves forward, it will be interesting to observe how these new manufacturing capabilities enhance the delivery of life-saving medical technologies and support healthcare professionals worldwide in tackling the respiratory challenges faced by patients today.